Skip to main content

Table 5 Regression analysis of individual trans fatty acids

From: Association of trans fatty acids with lipids and other cardiovascular risk factors in an Indian industrial population

Fatty acids TC TG HDL TC/HDL LDL Apo A1 Apo B hs CRP
C16:1 trans
 β Unadjusted (95% CI) 5.1 (− 8.5, 18.7) 26.5 (− 0.9, 53.8) − 2.2 (− 6.3, 1.9) 0.3 (− 0.2, 0.7) 10.6 (− 4.3, 25.4) − 1.6 (− 14.0, 10.7) 10.1 (− 0.2, 20.4) − 1.1 (− 5.3, 3.1)
 β Adjusted (95% CI)# 3.4 (− 7.1, 13.9) 20.9 (1.1, 40.7)* − 0.4 (− 3.3, 2.5) 0.1 (− 0.2, 0.4) 0.7 (− 9.4, 10.8) 0.2 (− 8.0, 8.4) 2.6 (− 4.5, 9.7) − 0.3 (− 3.4, 2.7)
C18:1 11 trans (Vaccenic acid)
 β Unadjusted (95% CI) − 22.1 (− 55.4, 11.2) 33.3 (− 34.5, 101.1) − 0.4 (− 10.6, 9.7) − 0.5 (− 1.6, 0.6) − 21.1 (− 53.0, 10.8) − 13 (− 39.4, 13.5) − 7.6 (− 30.0, 14.7) − 1.6 (− 10.7, 7.5)
 β Adjusted (95% CI)# − 25.6 (− 72.3, 21.1) 60.3 (− 34.1, 154.7) 0.3 (− 13.4, 14.1) − 0.8 (− 2.3, 0.7) − 25.6 (− 69.0, 17.8) − 16.5 (− 52.3, 19.3) − 4.8 (− 35.3, 25.7) − 4.9 (− 17.8, 8.0)
C18:1 9 trans (Elaidic acid)
 β Unadjusted (95% CI) − 5.3 (− 22.8, 12.2) 15.5 (− 20.1, 51.1) − 2.8 (− 8.1, 2.5) 0.2 (− 0.4, 0.7) − 12 (− 29.7, 5.7) 8.4 (− 6.3, 23.1) − 8.3 (− 20.7, 4.0) − 0.9 (− 6.0, 4.2)
 β Adjusted (95% CI)# − 11.4 (− 38.6, 15.8) 10.1 (− 45.1, 65.2) − 5.2 (− 13.2, 2.8) 0.2 (− 0.6, 1.1) − 20.4 (− 48.0, 7.1) 12.9 (− 9.8, 35.7) − 14.4 (− 33.7, 4.9) − 1.3 (− 9.5, 6.9)
  1. TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Apo A1, apolipoprotein A1; Apo B, apolipoprotein B; hs CRP, high sensitive c-reactive protein
  2. * Values are significant (p < 0.05)
  3. #Model adjusted with age, sex, bmi, diet, smoking and alcohol use